Filed Pursuant to Rule 424(b)(5)
Registration Statement No. 333-235277
PROSPECTUS SUPPLEMENT
(To Prospectus dated December 20, 2019)
Up to $400,000,000
Common Stock
We and Brixmor Operating Partnership L.P. have entered into equity distribution agreements (the “Sales Agreements”) relating to the issuance and sale of shares of our common stock, par value $0.01 per share, or “common stock,” offered by this prospectus supplement and the accompanying prospectus pursuant to a continuous offering program with each of Barclays Capital Inc., BMO Capital Markets Corp., BNY Mellon Capital Markets, LLC, BTIG, LLC, Citigroup Global Markets Inc., Jefferies LLC, Mizuho Securities USA LLC, RBC Capital Markets, LLC, Scotia Capital (USA) Inc. and SunTrust Robinson Humphrey, Inc. as Sales Agents (as defined below) and (except in the case of BTIG, LLC, Mizuho Securities USA LLC and SunTrust Robinson Humphrey, Inc.), the Forward Sellers (as defined below) and each of the Forward Purchasers (as defined below). We refer to these entities, when acting in their capacity as our sales agents, individually as a “Sales Agent” and collectively as the “Sales Agents” and, if applicable, when acting in their capacity as agents for the Forward Purchasers, individually as a “Forward Seller” and collectively as the “Forward Sellers.” In accordance with the terms of the Sales Agreements, up to $400 million of our common stock may be sold from time to time by us through the Sales Agents, by the Forward Sellers or by us directly to the Sales Agent acting as principals.
The Sales Agreements contemplate that, in addition to the issuance and sale of our shares of common stock by us through the Sales Agents (or to the Sales Agents acting as principals), we may also enter into one or more forward sale agreements from time to time in the future with each of Barclays Capital Inc., BMO Capital Markets Corp., BNY Mellon Capital Markets, LLC, Citigroup Global Markets Inc., Jefferies LLC, RBC Capital Markets, LLC and Scotia Capital (USA) Inc., Jefferies or one of their respective affiliates. We refer to these entities, when acting in such capacity, individually as a “Forward Purchaser” and collectively as the “Forward Purchasers.” In connection with any forward sale agreement, the relevant Forward Purchaser (or its affiliate) will, at our request, use commercially reasonable efforts, consistent with its normal trading and sales practices and applicable law and regulations, to borrow from third parties and sell, through its affiliated Forward Seller, a number of our shares of common stock equal to the number of shares of common stock underlying the particular forward sale agreement. We will not initially receive any proceeds from any sales of our common stock by a Forward Seller in connection with a forward sale agreement.
Subject to certain conditions, we generally have the right to elect physical, cash or net share settlement under the forward sale agreements. We expect to fully physically settle each forward sale agreement, if any, with the relevant Forward Purchaser on one or more dates specified by us on or prior to the maturity date of such forward sale agreement. We may also elect to either cash settle or net share settle our obligations under the forward sale agreements if we determine that is in our best interest to do so. If we elect to cash settle any forward sale agreement, we may not receive any proceeds, and we may owe cash to the relevant Forward Purchaser. If we elect to net share settle any forward sale agreement, we will not receive any proceeds, and we may owe shares of our common stock to the relevant Forward Purchaser. See “Plan of Distribution—Sales by Forward Sellers.”
Each Sales Agent will receive from us a commission at a mutually agreed rate that will not exceed, but may be lower than, 2.0% of the gross sales price of all shares of our common stock sold through it from time to time under the Sales Agreements. Each Forward Seller will receive from us a commission at a mutually agreed rate in the form of a reduction to the initial forward sale price under the related forward sale agreement that will not exceed, but may be lower than, 2.0% of the gross sales price of the borrowed shares sold by such Forward Seller during the applicable forward hedge selling period for such shares. In connection with sales of shares of our common stock pursuant to the Sales Agreements, each of the Sales Agents and the Forward Sellers may be deemed to be an “underwriter” within the meaning of the Securities Act of 1933, as amended (the “Securities Act”), and their compensation may be deemed to be underwriting compensation under Securities and Exchange Commission (“SEC”) rules. See “Plan of Distribution” beginning on pageS-10 of this prospectus supplement for additional information regarding compensation of the Sales Agents and the Forward Sellers.
Our shares of common stock trade on the New York Stock Exchange (the “NYSE”) under the symbol “BRX.” On January 8, 2020, the last sale price of our shares of common stock as reported on the NYSE was $20.46 per share.
Sales of the shares of our common stock, if any, made through the Sales Agents, acting as our sales agents, or the Forward Sellers, acting as agents for the applicable Forward Purchaser, or directly to a Sales Agent, acting as principal, as contemplated by this prospectus supplement and the accompanying prospectus, may be made by means of ordinary brokers’ transactions on the NYSE, by means of negotiated transactions or otherwise at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices and any other method permitted by applicable law.
Under the terms of the Sales Agreements, we also may sell shares of our common stock to each of the Sales Agents, as principal for its own account, at a price per share to be agreed upon at the time of sale. If we sell shares of our common stock to any Sales Agent, as principal, we will enter into a separate agreement with such Sales Agent, as applicable, setting forth the terms of such transaction.
No Sales Agent and no Forward Seller is required to sell any specific number or dollar amount of shares of our common stock but, subject to the terms and conditions of the Sales Agreements, each of the Sales Agents and Forward Sellers has agreed to use its commercially reasonable efforts, consistent with its normal trading and sales practices and applicable law and regulations, to sell all of the shares of our common stock so designated by us (if acting as our Sales Agent) and all of the borrowed shares (if acting as sales agent for the relevant Forward Purchaser), in each case, on the terms and subject to the conditions of the applicable Sales Agreement. The shares of our common stock offered and sold through the Sales Agents and by the Forward Sellers pursuant to the Sales Agreements will be offered and sold through only one Sales Agent or by one Forward Seller on any given trading day. The offering of shares of our common stock pursuant to the Sales Agreements will terminate upon the earliest of (i) the sale of shares of our common stock subject to the Sales Agreements (including shares sold by us to or through the Sales Agents and borrowed shares sold by the Forward Sellers) and any terms agreement having an aggregate gross sales price of $400,000,000, (ii) with respect to the Sales Agreements or terms agreement, the termination of the Sales Agreements by us, the Sales Agents, the Forward Sellers or the Forward Purchasers as permitted therein and (iii) January 9, 2023.
Our charter contains restrictions on the ownership and transfer of our common stock intended to assist us in maintaining our status as a real estate investment trust (“REIT”) for federal and/or state income tax purposes. For example, our charter generally restricts any person from actually or constructively owning more than 9.8% of the aggregate of the outstanding shares of our common stock by value or by number of shares, whichever is more restrictive, subject to certain conditions. See “Material Provisions of Maryland Law and of our Charter and Bylaws—Effect of Certain Provisions of Maryland Law and of our Charter and Bylaws” in the accompanying prospectus.
Investing in our common stock involves risks. See “Risk Factors” beginning on pageS-4 of this prospectus supplement and the risk factors beginning on page 5 of our most Annual Report on Form10-K for the year ended December 31, 2018, which is incorporated by reference herein. You should also consider any additional risk factors included in any document we file with the Securities and Exchange Commission that are incorporated, or deemed to be incorporated, by reference into this prospectus supplement prior to the completion of this offering.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus to which it relates is truthful or complete. Any representation to the contrary is a criminal offense.
| | | | |
Barclays | | BMO Capital Markets | | BNY Mellon Capital Markets, LLC |
| | | | | | |
BTIG | | Citigroup | | Jefferies | | Mizuho Securities |
| | | | |
Scotiabank | | SunTrust Robinson Humphrey | | RBC Capital Markets |
The date of this prospectus supplement is January 9, 2020.